Key Takeaways for the Management of Plaque Psoriasis
Experts in dermatology share final thoughts on the treatment of plaque psoriasis and the ever-changing treatment landscape.
Role of Diversity in Plaque Psoriasis Clinical Trials
Benjamin Lockshin, MD, FAAD, highlights diversity in clinical trials as an unmet need in approaching the treatment of plaque psoriasis.
Plaque Psoriasis Treatment Guidelines
Expert dermatologists discuss the treatment guidelines for plaque psoriasis, and how the decision about treatment is ultimately in the hands of the clinician.
Psychological Impact of Plaque Psoriasis
Nicholas Brownstone, MD, and James Q. Del Rosso, DO, comment on the psychological impact of plaque psoriasis on a patient’s quality of life.
Patient Case #3: 48-Year-Old Male With Plaque Psoriasis
Experts in dermatology review a patient case of a 48-year-old man with plaque psoriasis who is having trouble with topical therapy.
Patient Case #2: 60-Year-Old Female With Chronic Intertrigo
Dermatology experts discuss a patient case concerning a 60-year-old woman with chronic intertriginous psoriasis who is taking a biologic drug for inflammatory bowel disease.
Patient Case #1: 29-Year-Old Female With Plaque Psoriasis
Dawn L. Sammons, DO, FAOCD, FAAD, and Benjamin Lockshin, MD, FAAD, review a case of a female patient with a family history of plaque psoriasis.
Mechanism of Action of Tapinarof in Plaque Psoriasis
Experts discuss the unique mechanism of action of tapinarof and its use in the treatment of plaque psoriasis.
Efficacy of Tapinarof in Plaque Psoriasis
James Q. Del Rosso, DO, and Dawn L. Sammons, DO, FAOCD, FAAD, review the efficacy of a new topical agent in the treatment of plaque psoriasis, tapinarof, highlighting the remittive data.
Treatment Selection in Plaque Psoriasis
Experts in dermatology discuss newer topical treatments, such as tapinarof, in the management of plaque psoriasis.
Resident Training in Plaque Psoriasis
Nicholas Brownstone, MD, comments on how newer treatments in plaque psoriasis can impact residency training.
Topical vs Systemic Therapy in Plaque Psoriasis
Dawn L. Sammons, DO, FAOCD, FAAD, shares her approach to using topical vs systemic therapy in plaque psoriasis, focusing on patient preference as the driving factor for treatment selection.
Use of Topical Treatment in Plaque Psoriasis
Brad Glick, DO, FAOCD, highlights topical therapy as a targeted treatment of plaque psoriasis.
The Pathogenesis of Plaque Psoriasis
Benjamin Lockshin, MD, FAAD, comments on how the evolution of the pathophysiology of plaque psoriasis has led to more targeted therapies to treat the disease.
